Gene Gene information from NCBI Gene database.
Entrez ID 4036
Gene name LDL receptor related protein 2
Gene symbol LRP2
Synonyms (NCBI Gene)
DBSGP330LRP-2
Chromosome 2
Chromosome location 2q31.1
Summary The protein encoded by this gene, low density lipoprotein-related protein 2 (LRP2) or megalin, is a multi-ligand endocytic receptor that is expressed in many different tissues but primarily in absorptive epithilial tissues such as the kidney. This glycopr
SNPs SNP information provided by dbSNP.
37
SNP ID Visualize variation Clinical significance Consequence
rs35942532 T>C Uncertain-significance, conflicting-interpretations-of-pathogenicity Coding sequence variant, missense variant
rs80338743 T>C Pathogenic Genic upstream transcript variant, splice acceptor variant
rs80338744 G>A Pathogenic Coding sequence variant, stop gained, genic upstream transcript variant
rs80338745 A>C Pathogenic Splice donor variant, genic upstream transcript variant
rs80338747 A>G Pathogenic, likely-pathogenic Coding sequence variant, missense variant
miRNA miRNA information provided by mirtarbase database.
89
miRTarBase ID miRNA Experiments Reference
MIRT048169 hsa-miR-196a-5p CLASH 23622248
MIRT1117932 hsa-miR-1197 CLIP-seq
MIRT1117933 hsa-miR-1286 CLIP-seq
MIRT1117934 hsa-miR-1298 CLIP-seq
MIRT1117935 hsa-miR-190 CLIP-seq
Gene ontology (GO) Gene Ontology (GO) annotations describing the biological processes, molecular functions, and cellular components associated with a gene.
116
GO ID Ontology Definition Evidence Reference
GO:0001523 Process Retinoid metabolic process IEA
GO:0001523 Process Retinoid metabolic process TAS
GO:0001822 Process Kidney development IEA
GO:0001843 Process Neural tube closure IEA
GO:0001843 Process Neural tube closure ISS
Other IDs Other IDs provides unique identifiers for this gene in OMIM, HGNC, and Ensembl databases.
MIM HGNC e!Ensembl
600073 6694 ENSG00000081479
Protein Protein information from UniProt database.
UniProt ID Unique identifier for the protein in the UniProt database. Click to view detailed protein information.
P98164
Protein name Low-density lipoprotein receptor-related protein 2 (LRP-2) (Glycoprotein 330) (gp330) (Megalin)
Protein function Multiligand endocytic receptor (By similarity). Acts together with CUBN to mediate endocytosis of high-density lipoproteins (By similarity). Mediates receptor-mediated uptake of polybasic drugs such as aprotinin, aminoglycosides and polymyxin B
PDB 2M0P
Family and domains

Pfam

Accession ID Position in sequence Description Type
PF00057 Ldl_recept_a 26 62 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 65 103 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 106 142 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 181 217 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 220 256 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 264 301 Low-density lipoprotein receptor domain class A Repeat
PF00058 Ldl_recept_b 479 519 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 522 566 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 838 879 Low-density lipoprotein receptor repeat class B Repeat
PF00057 Ldl_recept_a 1024 1060 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 1065 1101 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 1107 1143 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 1147 1183 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 1185 1222 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 1228 1266 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 1269 1305 Low-density lipoprotein receptor domain class A Repeat
PF07645 EGF_CA 1390 1428 Calcium-binding EGF domain Domain
PF00058 Ldl_recept_b 1521 1561 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 1566 1607 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 1883 1928 Low-density lipoprotein receptor repeat class B Repeat
PF14670 FXa_inhibition 2022 2058 Domain
PF00058 Ldl_recept_b 2202 2243 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 2519 2560 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 2563 2601 Low-density lipoprotein receptor repeat class B Repeat
PF00057 Ldl_recept_a 2698 2736 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 2739 2775 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 2778 2817 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 2820 2859 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 2862 2899 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 2904 2943 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 2946 2988 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 2991 3027 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3030 3068 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3073 3109 Low-density lipoprotein receptor domain class A Repeat
PF12662 cEGF 3132 3155 Complement Clr-like EGF-like Domain
PF00058 Ldl_recept_b 3282 3330 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 3333 3374 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 3377 3417 Low-density lipoprotein receptor repeat class B Repeat
PF00057 Ldl_recept_a 3510 3548 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3551 3589 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3592 3630 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3633 3671 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3676 3714 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3717 3754 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3757 3793 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3796 3832 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3840 3878 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3881 3920 Low-density lipoprotein receptor domain class A Repeat
PF00057 Ldl_recept_a 3926 3962 Low-density lipoprotein receptor domain class A Repeat
PF07645 EGF_CA 4007 4047 Calcium-binding EGF domain Domain
PF00058 Ldl_recept_b 4154 4194 Low-density lipoprotein receptor repeat class B Repeat
PF00058 Ldl_recept_b 4197 4238 Low-density lipoprotein receptor repeat class B Repeat
Tissue specificity TISSUE SPECIFICITY: Expressed in first and third trimester cytotrophoblasts in the placenta (at protein level) (PubMed:27798286). Absorptive epithelia, including renal proximal tubules. {ECO:0000269|PubMed:27798286}.
Sequence
MDRGPAAVACTLLLALVACLAPASGQECDSAHFRCGSGHCIPADWRCDGTKDCSDDADEI
GC
AVVTCQQGYFKCQSEGQCIPNSWVCDQDQDCDDGSDERQDCSQSTCSSHQITCSNGQC
IPSEYRCDHVRDCPDGADENDC
QYPTCEQLTCDNGACYNTSQKCDWKVDCRDSSDEINCT
EICLHNEFSCGNGECIPRAYVCDHDNDCQDGSDEHACNYPTCGGYQFTCPSGRCIYQNWV
CDGEDDCKDNGDEDGC
ESGPHDVHKCSPREWSCPESGRCISIYKVCDGILDCPGREDENN
T
STGKYCSMTLCSALNCQYQCHETPYGGACFCPPGYIINHNDSRTCVEFDDCQIWGICDQ
KCESRPGRHLCHCEEGYILERGQYCKANDSFGEASIIFSNGRDLLIGDIHGRSFRILVES
QNRGVAVGVAFHYHLQRVFWTDTVQNKVFSVDINGLNIQEVLNVSVETPENLAVDWVNNK
IYLVETKVNRIDMVNLDGSYRVTLITENLGHPRGIAVDP
TVGYLFFSDWESLSGEPKLER
AFMDGSNRKDLVKTKLGWPAGVTLDM
ISKRVYWVDSRFDYIETVTYDGIQRKTVVHGGSL
IPHPFGVSLFEGQVFFTDWTKMAVLKANKFTETNPQVYYQASLRPYGVTVYHSLRQPYAT
NPCKDNNGGCEQVCVLSHRTDNDGLGFRCKCTFGFQLDTDERHCIAVQNFLIFSSQVAIR
GIPFTLSTQEDVMVPVSGNPSFFVGIDFDAQDSTIFFSDMSKHMIFKQKIDGTGREILAA
NRVENVESLAFDWISKNLYWTDSHYKSISVMRLADKTRRTVVQYLNNPRSVVVHPFAGYL
FFTDWFRPAKIMRAWSDGSHLLPVINTTLGWPNGLAIDW
AASRLYWVDAYFDKIEHSTFD
GLDRRRLGHIEQMTHPFGLAIFGEHLFFTDWRLGAIIRVRKADGGEMTVIRSGIAYILHL
KSYDVNIQTGSNACNQPTHPNGDCSHFCFPVPNFQRVCGCPYGMRLASNHLTCEGDPTNE
PPTEQCGLFSFPCKNGRCVPNYYLCDGVDDCHDNSDEQLCGTLNNTCSSSAFTCGHGECI
PAHWRCDKRNDCVDGSDEHNC
PTHAPASCLDTQYTCDNHQCISKNWVCDTDNDCGDGSDE
KNC
NSTETCQPSQFNCPNHRCIDLSFVCDGDKDCVDGSDEVGCVLNCTASQFKCASGDKC
IGVTNRCDGVFDCSDNSDEAGC
PTRPPGMCHSDEFQCQEDGICIPNFWECDGHPDCLYGS
DEHNAC
VPKTCPSSYFHCDNGNCIHRAWLCDRDNDCGDMSDEKDCPTQPFRCPSWQWQCL
GHNICVNLSVVCDGIFDCPNGTDESPLCNGNSCSDFNGGCTHECVQEPFGAKCLCPLGFL
LANDSKTCEDIDECDILGSCSQHCYNMRGSFRCSCDTGYMLESDGRTCKVTASESLLLLV
ASQNKIIADSVTSQVHNIYSLVENGSYIVAVDFDSISGRIFWSDATQGKTWSAFQNGTDR
RVVFDSSIILTETIAIDWVGRNLYWTDYALETIEVSKIDGSHRTVLISKNLTNPRGLALD
P
RMNEHLLFWSDWGHHPRIERASMDGSMRTVIVQDKIFWPCGLTIDYPNRLLYFMDSYLD
YMDFCDYNGHHRRQVIASDLIIRHPYALTLFEDSVYWTDRATRRVMRANKWHGGNQSVVM
YNIQWPLGIVAVHPSKQPNSVNPCAFSRCSHLCLLSSQGPHFYSCVCPSGWSLSPDLLNC
LRDDQPFLITVRQHIIFGISLNPEVKSNDAMVPIAGIQNGLDVEFDDAEQYIYWVENPGE
IHRVKTDGTNRTVFASISMVGPSMNLALDWISRNLYSTNPRTQSIEVLTLHGDIRYRKTL
IANDGTALGVGFPIGITVDPARGKLYWSDQGTDSGVPAKIASANMDGTSVKTLFTGNLEH
LECVTLDI
EEQKLYWAVTGRGVIERGNVDGTDRMILVHQLSHPWGIAVHDSFLYYTDEQY
EVIERVDKATGANKIVLRDNVPNLRGLQVYHRRNAAESSNGCSNNMNACQQICLPVPGGL
FSCACATGFKLNPDNRSC
SPYNSFIVVSMLSAIRGFSLELSDHSETMVPVAGQGRNALHV
DVDVSSGFIYWCDFSSSVASDNAIRRIKPDGSSLMNIVTHGIGENGVRGIAVDWVAGNLY
FTNAFVSETLIEVLRINTTYRRVLLKVTVDMPRHIVVDPKNRYLFWADYGQRPKIERSFL
DCTNRTVLVSEGIVTPRGLAVDR
SDGYVYWVDDSLDIIARIRINGENSEVIRYGSRYPTP
YGITVFENSIIWVDRNLKKIFQASKEPENTEPPTVIRDNINWLRDVTIFDKQVQPRSPAE
VNNNPCLENNGGCSHLCFALPGLHTPKCDCAFGTLQSDGKNCAISTENFLIFALSNSLRS
LHLDPENHSPPFQTINVERTVMSLDYDSVSDRIYFTQNLASGVGQISYATLSSGIHTPTV
IASGIGTADGIAFDWITRRIYYSDYLNQMINSMAEDGSNRTVIARVPKPRAIVLDPCQGY
LYWADWDTHAKIERATLGGNFRVPIVNSSLVMPSGLTLDY
EEDLLYWVDASLQRIERSTL
TGVDREVIVNAAVHAFGLTLY
GQYIYWTDLYTQRIYRANKYDGSGQIAMTTNLLSQPRGI
NTVVKNQKQQCNNPCEQFNGGCSHICAPGPNGAECQCPHEGNWYLANNRKHCIVDNGERC
GASSFTCSNGRCISEEWKCDNDNDCGDGSDEMESVC
ALHTCSPTAFTCANGRCVQYSYRC
DYYNDCGDGSDEAGC
LFRDCNATTEFMCNNRRCIPREFICNGVDNCHDNNTSDEKNCPDR
TCQSGYTKCHNSNICIPRVYLCDGDNDCGDNSDENPTYC
TTHTCSSSEFQCASGRCIPQH
WYCDQETDCFDASDEPASC
GHSERTCLADEFKCDGGRCIPSEWICDGDNDCGDMSDEDKR
HQC
QNQNCSDSEFLCVNDRPPDRRCIPQSWVCDGDVDCTDGYDENQNCTRRTCSENEFTC
GYGLCIPKIFRCDRHNDCGDYSDERGC
LYQTCQQNQFTCQNGRCISKTFVCDEDNDCGDG
SDELMHLC
HTPEPTCPPHEFKCDNGRCIEMMKLCNHLDDCLDNSDEKGCGINECHDPSIS
GCDHNCTDTLTSFYCSCRPGYKLMSDKRTCVDIDECTEMPFVCSQKCENVIGSYICKCAP
GYLREPDGKTCRQNSNIEPYLIFSNRYYLRNLTIDGYFYSLILEGLDNVVALDFDRVEKR
LYWIDTQRQVIERMFLNKTNKETIINHRLPAAESLAVDWVSRKLYWLDARLDGLFVSDLN
GGHRRMLAQHCVDANNTFCFDNPRGLALHP
QYGYLYWADWGHRAYIGRVGMDGTNKSVII
STKLEWPNGITIDY
TNDLLYWADAHLGYIEYSDLEGHHRHTVYDGALPHPFAITIFEDTI
YWTDWNTRTVEKGNKYDGSNRQTLVNTTHRPFDIHVYHPYRQPIVSNPCGTNNGGCSHLC
LIKPGGKGFTCECPDDFRTLQLSGSTYCMPMCSSTQFLCANNEKCIPIWWKCDGQKDCSD
GSDELALC
PQRFCRLGQFQCSDGNCTSPQTLCNAHQNCPDGSDEDRLLCENHHCDSNEWQ
CANKRCIPESWQCDTFNDCEDNSDEDSSHC
ASRTCRPGQFRCANGRCIPQAWKCDVDNDC
GDHSDEPIEEC
MSSAHLCDNFTEFSCKTNYRCIPKWAVCNGVDDCRDNSDEQGCEERTCH
PVGDFRCKNHHCIPLRWQCDGQNDCGDNSDEENC
APRECTESEFRCVNQQCIPSRWICDH
YNDCGDNSDERDC
EMRTCHPEYFQCTSGHCVHSELKCDGSADCLDASDEADCPTRFPDGA
YCQATMFECKNHVCIPPYWKCDGDDDCGDGSDEELHLC
LDVPCNSPNRFRCDNNRCIYSH
EVCNGVDDCGDGTDETEEHC
RKPTPKPCTEYEYKCGNGHCIPHDNVCDDADDCGDWSDEL
GC
NKGKERTCAENICEQNCTQLNEGGFICSCTAGFETNVFDRTSCLDINECEQFGTCPQH
CRNTKGSYECVCADGFTSMSDRPGKRC
AAEGSSPLLLLPDNVRIRKYNLSSERFSEYLQD
EEYIQAVDYDWDPKDIGLSVVYYTVRGEGSRFGAIKRAYIPNFESGRNNLVQEVDLKLKY
VMQPDGIAVDWVGRHIYWSDVKNKRIEVAKLDGRYRKWLISTDLDQPAAIAVNPKLGLMF
WTDWGKEPKIESAWMNGEDRNILVFEDLGWPTGLSIDY
LNNDRIYWSDFKEDVIETIKYD
GTDRRVIAKEAMNPYSLDIFEDQLYWISKEKGEVWKQNKFGQGKKEKTLVVNPWLTQVRI
FHQLRYNKSVPNLCKQICSHLCLLRPGGYSCACPQGSSFIEGSTTECDAAIELPINLPPP
CRCMHGGNCYFDETDLPKCKCPSGYTGKYCEMAFSKGISPGTTAVAVLLTILLIVVIGAL
AIAGFFHYRRTGSLLPALPKLPSLSSLVKPSENGNGVTFRSGADLNMDIGVSGFGPETAI
DRSMAMSEDFVMEMGKQPIIFENPMYSARDSAVKVVQPIQVTVSENVDNKNYGSPINPSE
IVPETNPTSPAADGTQVTKWNLFKRKSKQTTNFENPIYAQMENEQKESVAATPPPSPSLP
AKPKPPSRRDPTPTYSATEDTFKDTANLVKEDSEV
Sequence length 4655
Interactions View interactions
Pathways Pathway information has different metabolic/signaling pathways associated with genes.
  KEGG  Reactome
  Hedgehog signaling pathway
Thyroid hormone synthesis
Cholesterol metabolism
  Vitamin D (calciferol) metabolism
Cargo recognition for clathrin-mediated endocytosis
Clathrin-mediated endocytosis
Retinoid metabolism and transport
Associated diseases Disease associations from ClinVar categorized as Causal (Pathogenic/Likely Pathogenic) or Unknown.
1326
Causal Diseases associated with Pathogenic or Likely Pathogenic variants in ClinVar
Phenotype Name Clinical Significance dbSNP ID RCV Accession
Donnai-Barrow syndrome Likely pathogenic; Pathogenic rs1236195196, rs2105329431, rs866520787, rs2105467271, rs2105348670, rs753667280, rs372938477, rs768458485, rs2105326044, rs2528491247, rs80338754, rs760114690, rs2545699853, rs80338747, rs80338751
View all (17 more)
RCV001542647
RCV001542648
RCV004555887
RCV001849819
RCV001849820
RCV001849821
RCV002503452
RCV005025532
RCV002052164
RCV002302517
RCV000192936
RCV000490345
RCV003147074
RCV000010058
RCV000010059
RCV000010060
RCV000010061
RCV000010062
RCV000010063
RCV000010064
RCV000010065
RCV005030071
RCV005030110
RCV005014852
RCV005030302
RCV000020603
RCV000020604
RCV000033107
RCV000677416
RCV000767862
RCV000767863
RCV001269295
RCV001290362
Hearing impairment Likely pathogenic; Pathogenic rs2545755689, rs2545794648 RCV002291529
RCV002291530
LRP2-related disorder Likely pathogenic; Pathogenic rs753549113, rs768458485, rs1310470715 RCV003408014
RCV003408018
RCV004750949
Malignant tumor of urinary bladder Pathogenic rs867941074 RCV005934704
Unknown Diseases with uncertain, conflicting, or no pathogenic evidence in ClinVar
Phenotype Name Clinical Significance dbSNP ID RCV Accession
Acute myeloid leukemia Benign rs72880427 RCV005923846
Cervical cancer Likely benign rs779851629 RCV005934961
Cholangiocarcinoma Benign rs992812829 RCV005918107
Clear cell carcinoma of kidney Benign; Likely benign; Conflicting classifications of pathogenicity rs34564141, rs372927481, rs140586887 RCV005895968
RCV005913830
RCV005909222
Associations from Text MiningDisease associations identified through Pubtator
Disease Name Relationship Type References
Albuminuria Associate 19366958
Alcoholism Associate 24890784
Alzheimer Disease Associate 24366390, 25024348, 27241555
Arthritis Infectious Inhibit 18364044
Autism Spectrum Disorder Associate 22578327
Autistic Disorder Associate 22578327
Biliary Tract Neoplasms Associate 37341068
Breast Neoplasms Associate 18567755
Breast Neoplasms Inhibit 31120873
Burns Associate 18364044